No Detail Found!

Cross-linking catechins with neuro-regulatory model for autism spectrum disorder: A management in rats' experiment

Author(s)
Gulshad Wagan Departments of Anatomy, LUMHS Jamshoro, Pakistan
Pirya Nangdev Departments of Anatomy, LUMHS Jamshoro, Pakistan
Sameena Gul Memon Bilawal Medical College, LUMHS Jamshoro, Pakistan
Shamshad Bano Bilawal Medical College, LUMHS Jamshoro, Pakistan
Kahaf Naz Bilawal Medical College, LUMHS Jamshoro, Pakistan
Naveeta Rathi Department of Pharmacology, Bilawal Medical College, LUMHS Jamshoro – Pakistan
Abstract
Objective: To examine Catechins' protective potential for neurodegeneration in autism-induced rats while exploring new findings about the Brain-derived neurotrophic factor (BDNF) in serum. Methodology: This experimental study was conducted at Liaquat University of Medical & Health Sciences (LUMHS), Jamshoro from July 2019 to June 2020. A total of 25 Sprague-Dawley strain rats of healthy male gender aged seven weeks were used. These animals were distributed into five experimental groups based on Catechins doses by mouth for twenty-four days. The Primary Progressive Aphasia PPA+200 mg/kg Catechins treatment condition was used to induce the experimental group. We analysed BDNF level changes through ELISA method. The statistical evaluation employed ANOVA using the Post hoc Turkey test as the analysis method. Results: We found that BDNF levels returned to nor-mal levels within the groups who received Catechins treatment at III, IV, and V concentrations (compared to Group II), showing Catechins could potentially treat autism-like symptoms. The BDNF values measured in nano-grams per millilitre were Group I (13.1±0.3), fol-lowed by Group II (5.1±0.2) and Group III (9.8±0.3), Group IV (8.0±0.3), and then Group V (10.1±0.3). The BDNF concentration measured in Groups III, IV and V surpassed the BDNF level of Group II (PPA-induced) per results from a post-hoc Tukey's test at p<0.05 signi-ficance. Conclusion: The research found that Catechins treat-ment effectiveness against PPA-induced Autism Mouse models increased through elevated serum BDNF levels.
Publication Details
Page(s) 766-769
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Neurodegeneration, Catechins, BDNF, autism., propionic acid (PPA)
References
Hirota T,King BH .2023 .Autism Spectrum Disorder: A Review. JAMA, 329 : 157-168.
Usui N,Kobayashi H,Shimada S H .2023 .Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder. Int J Mol Sci, 24 : 5487-9.
Thomas SD,Abdalla S,Eissa N,Akour A,Jha NK,Ojha S .2024 .Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder. Pharmaceuticals, 17 : 831-5.
Olcha P,Winiarska-Mieczan A,Kwiecień M,Nowakowski Ł,Miturski A,Semczuk A .2022 .and Antidiabetic Properties of Tea Polyphenols-The Positive Impact of Regular Tea Consumption as an Element of Prophylaxis and Pharmacotherapy Support in Endometrial Cancer. Int J Mol Sci, 23 : 6703-7.
Mokra D,Joskova M,Mokry J. Therapeutic Effects of Green Tea Polyphenol (‒) - M .2022 .-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis. Int J Mol Sci, 24 : 340-5.
Zwolak I. .2021 .Epigallocatechin Gallate for Management of Heavy Metal-Induced Oxidative Stress: Mechanisms of Action, Efficacy, and Concerns. Int J Mol Sci, 22 : 4027-32.
Tang G,Xu Y,Zhang C,Wang N,Li H,Feng Y. Green,Tea Y. Green .2021 .Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism. , 10 : 1076-9.
Savino R,Medoro A,Ali S,Scapagnini G,Maes M,Davinelli S. .2023 .The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review. J Clin Med, 12 : 3520-4.
Nasiry D,Khalatbary AR .2024 .Natural polyphenols for the management of autism spectrum disorder: a review of efficacy and molecular mechanisms. Nutr Neurosci, 27 : 241-51.
Ntamo Y,Jack B,Ziqubu K,Mazibuko-Mbeje SE,Nkambule BB,Nyambuya TM .2024 .Epigallocatechin gallate as a nutraceutical to potentially target the metabolic syndrome: novel insights into therapeutic effects beyond its antioxidant and anti-inflammatory properties. Crit Rev Food Sci Nutr, 64 : 87-109.
Baranwal A,Aggarwal P,Rai A,Kumar N. Pharmacological,Actions N. Pharmacological .2022 .Underlying Mechanisms of Catechin: A Review. Mini Rev Med Chem, 22 : 821-33.
Colak H,Sariyer ET,Nogay NH .2023 .The effect of nutritional interventions reducing oxidative stress on behavioural and gastrointestinal problems in autism spectrum disorder. Int J Dev Neurosci, 83 : 135-164.
Winiarska-Mieczan A,Kwiecień M,Jachimowicz-Rogowska K,Donaldson J,Tomaszewska E,Baranowska-Wójcik E,Anti-Inflammatory E .2023 .Neuroprotective Effects of Polyphenols-Polyphenols as an Element of Diet Therapy in Depressive Disorders. Int J Mol Sci, 24 : 2258-63.
Özduran G,Becer E,Vatansever HS .2023 .The Role and Mechanisms of Action of Catechins in Neurodegenerative Diseases. J Am Nutr Assoc, 42 : 67-74.
Afzal O,Dalhat MH,Altamimi ASA,Rasool R,Alzarea SI,Almalki WH .2022 .. Green Tea Catechins Attenuate Neurodegenerative Diseases and Cognitive Deficits. Molecules, 27 : 7604-8.
Mamun AA,Shao C,Geng P,Wang S,Xiao J .2024 .. Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far? Int J Biol Sci, 20 : 1332-55.
Zhang Z,Zhang Y,Li J,Fu C,Zhang X .2021 .The Neuroprotective Effect of Tea Polyphenols on the Regulation of Intestinal Flora. Molecules, 26 : 3692-6.
Sachdeva P,Mehdi I,Kaith R,Ahmad F,Anwar MS .2022 .Potential natural products for the management of autism spectrum disorder. Ibrain, 8 : 365-76.
Tanaka M,Spekker E,Szabó Á,Polyák H,Vécsei L H .2022 .Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents-in celebration of 80th birthday of Professor Peter Riederer. J Neural Transm (Vienna), 129 : 627-42.
Ramezani M,Meymand AZ,Khodagholi F,Kamsorkh HM,Asadi E,Noori M .2023 .A role for flavonoids in the prevention and/or treatment of cognitive dysfunction, learning, and memory deficits: a review of preclinical and clinical studies. Nutr Neurosci, 26 : 156-72.
0

Citations

0

Downloads

58

Views